EVALUATION OF THE INTRADERMAL SENSITIVITY TEST IN PATIENTS SUBMITTED TO HETEROLOGOUS SEROTHERAPY

Registro completo de metadados
MetadadosDescriçãoIdioma
Autor(es): dc.contributorUniversidade Estadual Paulista (Unesp)-
Autor(es): dc.creatorAyres, J. A. [UNESP]-
Autor(es): dc.creatorBarraviera, B. [UNESP]-
Data de aceite: dc.date.accessioned2022-02-22T01:13:03Z-
Data de disponibilização: dc.date.available2022-02-22T01:13:03Z-
Data de envio: dc.date.issued2021-07-14-
Data de envio: dc.date.issued2021-07-14-
Data de envio: dc.date.issued1999-
Fonte completa do material: dc.identifierhttp://dx.doi.org/10.1590/S0104-79301999000200003-
Fonte completa do material: dc.identifierhttp://hdl.handle.net/11449/212337-
Fonte: dc.identifier.urihttp://educapes.capes.gov.br/handle/11449/212337-
Descrição: dc.descriptionThis review deals with heterologous sera produced and used in Brazil. The authors studied 64 patients. Of these, 35 had been attacked by domestic and wild animals and received antirabies serum; 20 had been bitten by venomous animals (snakes and scorpions) and were treated with specific antivenoms; and 9 had traumas and received antitetanic serum All these patients were submitted to the intradermal sensitivity test before, and 30 days after reveiving heterologous serotherapy. The following results obtained by the authors agree with those in literature: - The intradermal test using undiluted heterologous serum produced a more acute reaction than that using heterologous serum diluted 1:10; - The larger the volume of serum, the larger was the wheal directly after inoculation; - The antigenic concentration influenced the final local reaction; - The reading 30 minutes after inoculation was always higher than that 15 min after; - No systemic reaction was observed during the tests; - The use of promethazine as a prophylactic medication did not protect against the early reactions; - Tests performed 30 days after serotherapy showed a higher reactivity, probably due to sensitization; - The intradermal sensitivity test did not allow the authors to predict early reactions. After these observations, the authors do not recommend the intradermal sensitivity test for patients submitted to heterologous serotherapy. They, however, strongly recommend a careful observation during the infusion and clinical follow up in the first 24 hours.-
Descrição: dc.descriptionSão Paulo State University, Course for a Degree in Nursing, School of Medicine of Botucatu-
Descrição: dc.descriptionSão Paulo State University, Department of Tropical Diseases, School of Medicine of Botucatu and Center for the Study of Venoms and Venomous Animals-
Descrição: dc.descriptionSão Paulo State University, Course for a Degree in Nursing, School of Medicine of Botucatu-
Descrição: dc.descriptionSão Paulo State University, Department of Tropical Diseases, School of Medicine of Botucatu and Center for the Study of Venoms and Venomous Animals-
Formato: dc.format142-152-
Idioma: dc.languageen-
Publicador: dc.publisherCentro de Estudos de Venenos e Animais Peçonhentos - CEVAP, Universidade Estadual Paulista - UNESP-
Relação: dc.relationJournal of Venomous Animals and Toxins-
Direitos: dc.rightsAcesso aberto-
???dc.source???: dc.sourceSciELO-
Palavras-chave: dc.subjectsensitivity test-
Palavras-chave: dc.subjectheterologous serotherapy-
Título: dc.titleEVALUATION OF THE INTRADERMAL SENSITIVITY TEST IN PATIENTS SUBMITTED TO HETEROLOGOUS SEROTHERAPY-
Tipo de arquivo: dc.typelivro digital-
Aparece nas coleções:Repositório Institucional - Unesp

Não existem arquivos associados a este item.